Physician

Dicky Girish Bhagat, M.D

According to 2025 Medicare claims, Dicky Bhagat, M.D (NPI: 1518960525) practices internal medicine in the Elkhart-Goshen, IN market, with the plurality of this provider's patient population coming from Elkhart, IN. This provider's primary affiliated billing organization is GOSHEN MEDICAL PRACTICE,LLC (NPI: 1861582694; TIN: 200296383) and primary practice location at 46526-6943. Bhagat is affiliated with the Indiana Lakes ACO (ACO ID: A1494) and CHA ACO, LLC (ACO ID: A2207), participating under the MSSP model.

Bhagat's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 319 traditional Medicare patients, billed 30,809 HCPCS/CPT codes, and received $337,509 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 8,561 prescription claims across 448 beneficiaries totaling $749,917 in drug costs, led by Eliquis (Apixaban). DME data shows 674 claims. Open Payments data shows 54 records totaling $1,527. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have changed little. In contrast, DME billing represents a smaller volume and did not follow a clear longitudinal pattern.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	498	22,079	$318,794
2016	470	22,524	$358,978
2017	466	21,046	$330,483
2018	465	31,209	$271,361
2019	423	43,023	$262,766
2020	391	33,205	$238,908
2021	364	27,539	$234,007
2022	349	36,145	$239,286
2023	326	34,027	$316,120
2024	319	30,809	$337,509

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	542	9,675	$831,315
2016	520	9,851	$857,027
2017	506	10,091	$811,414
2018	489	9,432	$782,392
2019	488	8,968	$725,616
2020	472	8,865	$718,741
2021	462	8,668	$791,213
2022	447	8,139	$822,789
2023	446	8,608	$899,575
2024	448	8,561	$749,917

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	260	1,015	$57,005
2016	251	873	$51,502
2017	260	990	$61,768
2018	158	821	$44,788
2019	125	684	$52,314
2020	113	797	$119,466
2021	97	669	$101,420
2022	96	735	$98,782
2023	114	698	$77,944
2024	113	674	$83,625

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	267	267	$120
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	275	742	$84
99490	Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month	296	1,449	$45
G0444	Annual depression screening, 5 to 15 minutes	265	265	$17
G0442	Annual alcohol misuse screening, 5 to 15 minutes	281	281	$17

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	83	5,605	$110,414
Trulicity	Dulaglutide	45	1,602	$52,017
Arexvy	Rsvpref3 Antigen/As01e/Pf	121	904	$37,408
Xarelto	Rivaroxaban	22	1,980	$37,094
Jardiance	Empagliflozin	29	1,643	$32,060

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7677	Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram	N	N/R	57	$50,776
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	30	$12,136
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	54	$3,889
J7605	Arformoterol, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 15 micrograms	N	N/R	63	$3,861
Q0513	Pharmacy dispensing fee for inhalation drug(s); per 30 days	N	19	99	$2,432

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	54	$1,527	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Dicky Girish Bhagat, M.D?

Tedicare shows public-source Medicare data for Dicky Girish Bhagat, M.D (NPI 1518960525), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Dicky Girish Bhagat, M.D have ACO affiliation data?

Dicky Girish Bhagat, M.D is shown with ACO affiliation data for Indiana Lakes ACO (MSSP, ACO ID A1494) and CHA ACO, LLC (MSSP, ACO ID A2207).

What billing organization is linked to Dicky Girish Bhagat, M.D?

Dicky Girish Bhagat, M.D is linked to GOSHEN MEDICAL PRACTICE,LLC (billing NPI 1861582694) in the available physician profile data.

Does Dicky Girish Bhagat, M.D have Open Payments data?

Dicky Girish Bhagat, M.D has 54 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.